On the 31st of March, Arrowpoint Asset Management bought 2.3 million 2U, Inc. (NASDAQ:TWOU) shares for $88 million at an average ...

CHICAGO - Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a $742 million market cap pharmaceutical company whose stock has surged 116% over the past year, has announced the FDA approval of its ...

Xeris Pharmaceuticals Inc. (XERS), with a market capitalization of $562 million, reported its fourth-quarter 2024 earnings, surpassing expectations with an earnings per share (EPS) of -0.03, compared ...

CHICAGO - Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a $742 million market cap pharmaceutical company whose stock has surged 116% over the past year, has announced the FDA approval of its ...

Xeris Biopharma (XERS), a fast-growing biopharmaceutical company, beat top and bottom-line expectations for Q4 and announced it is expecting ...

and Xeris Pharmaceuticals® (Xeris BioPharma Holdings, Inc.), a national supporter of the ADA, are pleased to announce a multi-year strategic partnership to reinforce the importance of prescribing ...

Xeris Pharmaceuticals is bringing research operations to the corporate hot spot, countering a cold leasing market and bucking a life sciences industry trend of ditching Chicago.

"I desired an improved means to travel in places where a wheelchair cannot maneuver," said an inventor, from Louisville, Ky. "This inspired me to create a chair that could easily be pushed and pulled ...